KNT-CT Holdings Co.,Ltd. Logo

KNT-CT Holdings Co.,Ltd.

A travel holding company offering themed tours and corporate travel solutions to boost Japan tourism.

9726 | T

Overview

Corporate Details

ISIN(s):
JP3260400001
LEI:
Country:
Japan
Address:
新宿区西新宿二丁目6番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

KNT-CT Holdings Co., Ltd. is a holding company that oversees a group of 22 companies primarily engaged in the travel and tourism industry. The group's core businesses are operated through its main subsidiaries, Kinki Nippon Tourist and Club Tourism. Kinki Nippon Tourist provides a wide range of travel products and professional consulting services to both corporate and individual clients. Club Tourism is a membership-based organization with seven million members, specializing in planning and selling unique, themed travel products. The holding company focuses on management strategy and administration for the group, with a strategic emphasis on expanding inbound tourism to Japan and contributing to domestic regional revitalization through comprehensive tourism solutions and event management.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-13 04:18
Registration Form
確認書
Japanese 8.2 KB
2025-11-13 04:16
Interim Report
半期報告書-第89期(2025/04/01-2026/03/31)
Japanese 202.6 KB
2025-06-18 08:07
Post-Annual General Meeting Information
臨時報告書
Japanese 27.2 KB
2025-06-16 06:57
Governance Information
内部統制報告書-第88期(2024/04/01-2025/03/31)
Japanese 22.9 KB
2025-06-16 06:56
Registration Form
確認書
Japanese 8.1 KB
2025-06-16 06:54
Annual Report
有価証券報告書-第88期(2024/04/01-2025/03/31)
Japanese 1.6 MB
2025-05-13 09:04
M&A Activity
臨時報告書
Japanese 19.3 KB
2025-05-13 09:03
Board/Management Information
臨時報告書
Japanese 21.4 KB
2025-03-21 03:58
Regulatory News Service
臨時報告書
Japanese 19.8 KB
2024-11-13 01:44
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-13 01:43
Interim Report
半期報告書-第88期(2024/04/01-2025/03/31)
Japanese 209.2 KB
2024-08-09 08:57
M&A Activity
臨時報告書
Japanese 19.6 KB
2024-06-17 06:06
Post-Annual General Meeting Information
臨時報告書
Japanese 24.7 KB
2024-06-14 07:16
Governance Information
内部統制報告書-第87期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-14 07:15
Registration Form
確認書
Japanese 8.2 KB

Automate Your Workflow. Get a real-time feed of all KNT-CT Holdings Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KNT-CT Holdings Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KNT-CT Holdings Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.